US Drug Recall Register
Class III · Low risk Terminated Initiated Feb 15, 2017 (10 years ago)

Zenatane

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Failed dissolution specifications - low dissolution results at S3 stage.

What was recalled

Zenatane (isotretinoin) capsules, 20 mg, packaged in 30-count cartons (3 x 10 blister cards), Rx Only, Manufactured By:Cipla Limited Kurkumbh Village Pune 413802 India, Manufactured For: Dr. Reddy's Laboratories, Bachupally 500 090 India, NDC 55111-136-81

Recalling firm
Dr. Reddy's Laboratories, Inc.
NDC code
55111-136-81
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0507-2017

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Isotretinoin recalls

See all
Class II · Moderate risk Ongoing

Claravis

Reason Failed Impurities/Degradation Specifications: Out of specification for specific impurity Tretinoin

Teva Pharmaceuticals USA, Inc NDC 0555-1054-56 D-0521-2026
Class II · Moderate risk Ongoing

Amnesteem

Reason Failed Dissolution Specifications

Mylan Pharmaceuticals INC NDC 0378-6614-93 D-0399-2026
Class II · Moderate risk Ongoing

Isotretinoin Capsules

Reason Superpotent and Subpotent

Teva Pharmaceuticals USA, Inc NDC 0591-2436-15 D-0446-2026
Class II · Moderate risk Ongoing

Isotretinoin Capsules

Reason Superpotent and Subpotent

Teva Pharmaceuticals USA, Inc NDC 0591-2435-15 D-0445-2026
Class II · Moderate risk Ongoing

Isotretinoin Capsules

Reason Superpotent Drug: The 3-month stability result for assay was found to be above specification limit

Teva Pharmaceuticals USA, Inc NDC 0591-2436-45 D-0439-2024